Literature DB >> 20126470

GAS6/AXL axis regulates prostate cancer invasion, proliferation, and survival in the bone marrow niche.

Yusuke Shiozawa1, Elisabeth A Pedersen, Lalit R Patel, Anne M Ziegler, Aaron M Havens, Younghun Jung, Jingcheng Wang, Stephanie Zalucha, Robert D Loberg, Kenneth J Pienta, Russell S Taichman.   

Abstract

Our recent studies have shown that annexin II, expressed on the cell surface of osteoblasts, plays an important role in the adhesion of hematopoietic stem cells (HSCs) to the endosteal niche. Similarly, prostate cancer (PCa) cells express the annexin II receptor and seem to use the stem cell niche for homing to the bone marrow. The role of the niche is thought to be the induction and sustenance of HSC dormancy. If metastatic PCa cells occupy a similar or the same ecological niche as HSCs, then it is likely that the initial role of the HSC niche will be to induce dormancy in metastatic cells. In this study, we demonstrate that the binding of PCa to annexin II induces the expression of the growth arrest-specific 6 (GAS6) receptors AXL, Sky, and Mer, which, in the hematopoietic system, induce dormancy. In addition, GAS6 produced by osteoblasts prevents PCa proliferation and protects PCa from chemotherapy-induced apoptosis. Our results suggest that the activation of GAS6 receptors on PCa in the bone marrow environment may play a critical role as a molecular switch, establishing metastatic tumor cell dormancy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20126470      PMCID: PMC2814350          DOI: 10.1593/neo.91384

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  56 in total

Review 1.  Blood and bone: two tissues whose fates are intertwined to create the hematopoietic stem-cell niche.

Authors:  Russell S Taichman
Journal:  Blood       Date:  2004-12-07       Impact factor: 22.113

2.  SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells.

Authors:  Mark J Kiel; Omer H Yilmaz; Toshihide Iwashita; Osman H Yilmaz; Cox Terhorst; Sean J Morrison
Journal:  Cell       Date:  2005-07-01       Impact factor: 41.582

3.  GAS6, the ligand of Axl and Rse receptors, is expressed in hematopoietic tissue but lacks mitogenic activity.

Authors:  G C Avanzi; M Gallicchio; G Cavalloni; L Gammaitoni; F Leone; A Rosina; R Boldorini; G Monga; L Pegoraro; B Varnum; M Aglietta
Journal:  Exp Hematol       Date:  1997-11       Impact factor: 3.084

4.  Cells of the osteoclast lineage as mediators of the anabolic actions of parathyroid hormone in bone.

Authors:  Amy J Koh; Burak Demiralp; Kathleen G Neiva; Joanna Hooten; Rahime M Nohutcu; Hyunsuk Shim; Nabanita S Datta; Russell S Taichman; Laurie K McCauley
Journal:  Endocrinology       Date:  2005-08-04       Impact factor: 4.736

5.  Functional heterogeneity of human CD34(+) cells isolated in subcompartments of the G0 /G1 phase of the cell cycle.

Authors:  A Gothot; R Pyatt; J McMahel; S Rice; E F Srour
Journal:  Blood       Date:  1997-12-01       Impact factor: 22.113

6.  Metastasis-associated protein S100A4 induces angiogenesis through interaction with Annexin II and accelerated plasmin formation.

Authors:  Alexandre Semov; Maria J Moreno; Anatoli Onichtchenko; Abedelnasser Abulrob; Marguerite Ball; Irena Ekiel; Grzegorz Pietrzynski; Danica Stanimirovic; Valery Alakhov
Journal:  J Biol Chem       Date:  2005-03-23       Impact factor: 5.157

7.  A receptor tyrosine kinase, UFO/Axl, and other genes isolated by a modified differential display PCR are overexpressed in metastatic prostatic carcinoma cell line DU145.

Authors:  A N Jacob; J Kalapurakal; W R Davidson; G Kandpal; N Dunson; Y Prashar; R P Kandpal
Journal:  Cancer Detect Prev       Date:  1999

8.  Gas6 induces proliferation in prostate carcinoma cell lines expressing the Axl receptor.

Authors:  Pier Paolo Sainaghi; Luigi Castello; Luca Bergamasco; Margherita Galletti; Paola Bellosta; Gian Carlo Avanzi
Journal:  J Cell Physiol       Date:  2005-07       Impact factor: 6.384

9.  Axl expression is associated with adverse prognosis and with expression of Bcl-2 and CD34 in de novo acute myeloid leukemia (AML): results from a multicenter trial of the Swiss Group for Clinical Cancer Research (SAKK).

Authors:  C Rochlitz; A Lohri; M Bacchi; M Schmidt; S Nagel; M Fopp; M F Fey; R Herrmann; A Neubauer
Journal:  Leukemia       Date:  1999-09       Impact factor: 11.528

10.  Receptor tyrosine kinase expression in human bone marrow stromal cells.

Authors:  K Satomura; A R Derubeis; N S Fedarko; K Ibaraki-O'Connor; S A Kuznetsov; D W Rowe; M F Young; P Gehron Robey
Journal:  J Cell Physiol       Date:  1998-12       Impact factor: 6.384

View more
  133 in total

1.  The interconnectedness of cancer cell signaling.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2011-12       Impact factor: 5.715

2.  Bone Microenvironment Changes in Latexin Expression Promote Chemoresistance.

Authors:  Mi Zhang; Mary Osisami; Jinlu Dai; Jill M Keller; June Escara-Wilke; Atsushi Mizokami; Evan T Keller
Journal:  Mol Cancer Res       Date:  2017-01-13       Impact factor: 5.852

3.  Autocrine and Paracrine Interactions between Multiple Myeloma Cells and Bone Marrow Stromal Cells by Growth Arrest-specific Gene 6 Cross-talk with Interleukin-6.

Authors:  Miki Furukawa; Hiroshi Ohkawara; Kazuei Ogawa; Kazuhiko Ikeda; Koki Ueda; Akiko Shichishima-Nakamura; Emi Ito; Jun-Ichi Imai; Yuka Yanagisawa; Reiko Honma; Shinya Watanabe; Satoshi Waguri; Takayuki Ikezoe; Yasuchika Takeishi
Journal:  J Biol Chem       Date:  2017-01-31       Impact factor: 5.157

Review 4.  Novel approaches to target the microenvironment of bone metastasis.

Authors:  Lorenz C Hofbauer; Aline Bozec; Martina Rauner; Franz Jakob; Sven Perner; Klaus Pantel
Journal:  Nat Rev Clin Oncol       Date:  2021-04-19       Impact factor: 66.675

Review 5.  Targeting the tumour stroma to improve cancer therapy.

Authors:  Kenneth C Valkenburg; Amber E de Groot; Kenneth J Pienta
Journal:  Nat Rev Clin Oncol       Date:  2018-06       Impact factor: 66.675

Review 6.  Molecular pathways: niches in metastatic dormancy.

Authors:  Kenji Yumoto; Matthew R Eber; Janice E Berry; Russell S Taichman; Yusuke Shiozawa
Journal:  Clin Cancer Res       Date:  2014-04-22       Impact factor: 12.531

Review 7.  TAM receptor signaling in immune homeostasis.

Authors:  Carla V Rothlin; Eugenio A Carrera-Silva; Lidia Bosurgi; Sourav Ghosh
Journal:  Annu Rev Immunol       Date:  2015-01-14       Impact factor: 28.527

Review 8.  TYRO3: A potential therapeutic target in cancer.

Authors:  Pei-Ling Hsu; Jonathan Jou; Shaw-Jenq Tsai
Journal:  Exp Biol Med (Maywood)       Date:  2019-02-02

9.  Proteomic profiling of androgen-independent prostate cancer cell lines reveals a role for protein S during the development of high grade and castration-resistant prostate cancer.

Authors:  Punit Saraon; Natasha Musrap; Daniela Cretu; George S Karagiannis; Ihor Batruch; Chris Smith; Andrei P Drabovich; Dominique Trudel; Theodorus van der Kwast; Colm Morrissey; Keith A Jarvi; Eleftherios P Diamandis
Journal:  J Biol Chem       Date:  2012-08-20       Impact factor: 5.157

10.  Mer Tyrosine Kinase Regulates Disseminated Prostate Cancer Cellular Dormancy.

Authors:  Frank C Cackowski; Matthew R Eber; James Rhee; Ann M Decker; Kenji Yumoto; Janice E Berry; Eunsohl Lee; Yusuke Shiozawa; Younghun Jung; Julio A Aguirre-Ghiso; Russell S Taichman
Journal:  J Cell Biochem       Date:  2016-11-10       Impact factor: 4.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.